...
首页> 外文期刊>Molecular pharmaceutics >Computational Modeling of Hydroxypropyl-Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin Interactions: A Systematic Coarse-Graining Approach
【24h】

Computational Modeling of Hydroxypropyl-Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin Interactions: A Systematic Coarse-Graining Approach

机译:羟丙基 - 甲基纤维素乙酸酯琥珀酸酯(HPMCAS)和苯妥林相互作用的计算模拟:一种系统粗磨的方法

获取原文
获取原文并翻译 | 示例
           

摘要

We present coarse-grained (CG) force fields for hydroxypropylmethylcellulose acetate succinate (HPMCAS) polymers and the drug molecule phenytoin using a bead/stiff spring model, with each bead representing a HPMCAS monomer or monomer side group (hydroxypropyl acetyl, acetyl, or succinyl) or a single phenytoin ring. We obtain the bonded and nonbonded interaction parameters in our CG model using the RDFs from atomistic simulations of short HPMCAS model oligomers (20-mer) and atomistic simulations of phenytoin molecules. The nonbonded interactions are modeled using a IJ 12-6 potential, with separate parameters for each monomer substitution type, which allows heterogeneous polymer chains to be modeled. The cross interaction terms between the polymer and phenytoin CG beads are obtained explicitly from atomistic level polymer phenytoin simulations, rather than from mixing rules. We study the solvation behavior of 50-mer and 100-mer polymer chains and find chain-length-dependent aggregation. We also compare the phenytoin CG force field developed in this work with that in Mandal et al. (Soft Matter, 2016, 12, 8246-8255) and conclude both are suitable for studying the interaction between polymer and drug in solvated solid dispersion formulation, in the absence of drug crystallization. Finally, we present simulations of heterogeneous HPMCAS model polymer chains and phenytoin molecules. Polymer and drug form a complex in a short period of simulation time due to strong intermolecular interactions. Moreover, the protonated polymer chains are more effective than deprotonated ones in inhibiting the drug aggregation in the polymer-drug complex.
机译:我们用珠/刚的弹簧模型向羟丙基甲基纤维素(HPMCAS)聚合物和药物分子苯妥汀的粗粒(CG)力域和药物分子苯妥汀,每个珠子代表HPMCAs单体或单体侧基(羟丙基,乙酰基,甲甲酯或琥珀酰基)或单一的苯萘鞘。我们利用来自Short HPMCAS模型低聚物(20-ME1)的原子模拟的RDF获得CG模型中的粘合和非粘合的相互作用参数(20-MER)和苯体素分子原子模拟。使用IJ 12-6电位建模非粘合的相互作用,每个单体取代型具有单独的参数,其允许模拟异质聚合物链。聚合物和苯妥辛CG珠之间的交叉相互作用术语是明确地从原子水平聚合物苯妥林模拟中获得的,而不是混合规则。我们研究了50-MEL和100 MEL聚合物链的溶剂化行为,发现链长依赖性聚集。我们还比较了在Mandal等人的工作中开发的苯妥本CG力领域。 (柔软物质,2016,12,8246-8255)和结论既适用于研究溶剂化固体分散体制剂中的聚合物和药物之间的相互作用,在没有药物结晶的情况下。最后,我们呈现异质HPMCAS模型聚合物链和苯体素分子的模拟。聚合物和药物在短时间内形成复合物,由于强的分子间相互作用。此外,质子化的聚合物链比抑制聚合物 - 药物复合物中的药物聚集在抑制药物聚集中更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号